A bipartisan group of six senators yesterday urged Senate leadership to include in a year-end package, legislation that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B drug savings program. The Centers for Medicare & Medicaid Services last month finalized a rule that reduces by nearly 30%, or $1.6 billion, Medicare payments to certain public and non-profit hospitals for outpatient drugs purchased under the 340B program. “As talks continue on end of the year packages, we urge you to work with us to prevent these cuts,” the senators wrote to Senate Majority Leader Mitch McConnell (R-KY) and Minority Leader Chuck Schumer (D-NY). Sens. John Thune (R-SD), Rob Portman (R-OH), Shelley Moore Capito (R-WV), Debbie Stabenow (D-MI), Tammy Baldwin (D-WI) and Bill Nelson (D-FL) signed the letter. Reps. David McKinley (R-WV) and Mike Thompson (D-CA) have introduced H.R. 4392, a bill that would prevent the cuts to the 340B program from being implemented.

Related News Articles

Headline
The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s request for a preliminary injunction…
Perspective
Public
Every health care provider strives to deliver their patients the best possible care, but not all providers offer the same level or complexity of care. Current…
Headline
A JAMA internal medicine study published Sept. 8 found that since the COVID-19 pandemic, Medicare Advantage beneficiaries have been experiencing longer…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 3 released a study conducted by KNG Health Consulting that found Medicare patients who receive care in a hospital outpatient department are more…